Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M13.8Revenue $M2.5Net Margin (%)-291.1Altman Z-Score-93.0
Enterprise Value $M14.0EPS $-0.8Operating Margin %-268.5Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.1Pre-tax Margin (%)-291.1Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio0.7Cash flow > EarningsY
Price/Sales5.75-y EBITDA Growth Rate %-46.9Current Ratio0.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-110.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-1,392.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M8.7ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with BGMD

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

BGMD is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


BGMD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
AFEYAN NOUBARDirector, 10% Owner 2015-07-27Sell302$2.27-25.55 view
AFEYAN NOUBARDirector, 10% Owner 2015-07-27Sell4,980$2.27-25.55 view
KANIA EDWIN M JR10% Owner 2014-12-11Sell634,390$0.32428.13 view
AFEYAN NOUBARDirector, 10% Owner 2014-12-03Sell260$0.46267.39 view
AFEYAN NOUBARDirector, 10% Owner 2014-12-03Sell257$0.46267.39 view
AFEYAN NOUBARDirector, 10% Owner 2014-12-03Sell1,848$0.46267.39 view
AFEYAN NOUBARDirector, 10% Owner 2014-12-03Sell2,463$0.46267.39 view
PAPADOPOULOS STELIOSDirector 2013-01-30Buy250,000$2-15.5 view
AFEYAN NOUBARDirector, 10% Owner 2013-01-30Buy2,000,000$2-15.5 view
Posner Brian SDirector 2012-11-19Buy10,000$1.1744.44 view

Quarterly/Annual Reports about BGMD:

    News about BGMD:

    Articles On GuruFocus.com
    comment on BGMD Jun 09 2011 

    More From Other Websites
    BG Medicine Welcomes U.S. Market Introduction of Automated Galectin-3 Test at the 2015 American... Jul 27 2015
    Multiple Studies Show Superiority of Critical Diagnostics’ ST2 over BNP, NT-proBNP and Other Heart... Jul 24 2015
    BG MEDICINE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale... Jul 15 2015
    BG Medicine Announces Payoff of Secured Term Loan Jul 15 2015
    BG MEDICINE, INC. Financials Jul 14 2015
    BG MEDICINE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 08 2015
    BG Medicine Announces One-for-Four Reverse Stock Split Jul 08 2015
    BG Medicine Announces One-for-Four Reverse Stock Split Jul 08 2015
    BG MEDICINE, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jul 07 2015
    BG MEDICINE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 06 2015
    First Automated Test for Galectin-3 Now Available in U.S. Jul 06 2015
    BG MEDICINE, INC. Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Creation of a... Jun 09 2015
    10-Q for BG Medicine, Inc. May 17 2015
    BG MEDICINE, INC. Files SEC form 10-Q, Quarterly Report May 15 2015
    BG Medicine Reports First Quarter 2015 Financial Results May 14 2015
    BG MEDICINE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events,... May 14 2015
    BG Medicine Reports First Quarter 2015 Financial Results May 14 2015
    Q1 2015 BG Medicine Inc Earnings Release - Before Market Open May 14 2015
    BG MEDICINE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... May 12 2015
    BG Medicine Announces Q1 2015 Financial Results Release Date and Conference Call Information May 07 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK